Linked Life Data

9821616

Source:http://linkedlifedata.com/resource/pubmed/id/9821616

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1999-1-20
pubmed:abstractText
Doxorubicin and epirubicin are strong antineoplastic agents widely used in chemotherapy. One major complication of their use is skin sloughing after subcutaneous extravasation, the degree of which is often underestimated. Both drugs have a tendency to produce liquefying necrosis in soft tissue and chronic ulcers if extravasation occurs. Three cases of extravasation, their surgical treatment and final results are presented. In cases of doxorubicin and epirubicin extravasation it is very important to perform an early extensive surgical débridement with delayed closure to avoid long hospitalization and disabling results.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0266-7681
pubmed:author
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
666-8
pubmed:dateRevised
2009-6-8
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
Surgical management after doxorubicin and epirubicin extravasation.
pubmed:affiliation
Department of Plastic and Hand Surgery, Ferdinand Sauerbruch Klinikum, Wuppertal, Germany.
pubmed:publicationType
Journal Article, Case Reports